[Skip to Content]
Allergy and Clinical Immunology

Dose-Finding Trial of Epicutaneous vs Placebo Peanut Protein Immunotherapy for Peanut Sensitivity

JAMA
Published Online: November 14, 2017 Video 2 min 4 sec

This video summarizes a phase 2b randomized trial that compares adverse events and efficacy of 3 doses of a peanut protein patch for the treatment of peanut sensitivity in patients aged 6 to 55 years.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Related Articles

  1. Evolution of Guidelines on Peanut Introduction in Infants

  2. Implementing Peanut Allergy Prevention Guidelines at a Population Level

  3. Effect of Epicutaneous Immunotherapy vs Placebo on Peanut Protein Sensitivity

  4. Treatments for Food Allergies

See More

See More About

Allergy and Clinical Immunology Dermatology Guidelines Pediatrics Patient Information JAMA Patient Information
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue